Blair Capel has a diverse work experience, starting as a Talk Show Intern at Curtis Media Group in 2013. They then worked as a Legal File Assistant at Smith Anderson until 2015. In 2017, they joined PwC as an Assurance Associate before being promoted to Experienced Associate. In 2019, they moved to Deloitte as a Business Valuation Consultant. Blair then transitioned to Locus Biosciences, Inc. as an Associate Director of Finance/Controller, handling all aspects of the finance function. They continued to build and lead an in-house finance team. From 2022 to 2023, Blair served as the Director of Finance at Locus Biosciences, Inc., reporting to the CFO and overseeing the day-to-day finance operations. Currently, they hold the role of Director of Finance/Controller at Aer Therapeutics, Inc., where they are responsible for finance and accounting, corporate financial strategy, investor relations, HR, and IT functions.
Blair Capel holds a Master of Accounting degree from the University of Southern California. Prior to that, Capel earned a Bachelor of Science in Accounting with a focus on Internal Audit from North Carolina State University.
This person is not in any teams
This person is not in any offices
Aer Therapeutics, Inc.
Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs. We are focused on treating respiratory diseases with significant unmet need, such as COPD, cystic fibrosis and asthma. Our technology was developed and spun out of Dr. John Fahy’s airway biology lab at University of California San Francisco (UCSF) in collaboration with Dr. Stefan Oscarson’s glycochemistry lab at University College Dublin and Dr. Anne Marie Healy’s pharmaceutics lab at Trinity College Dublin. The efforts of this research consortium led to over $18M in NIH grant funding, resulting in the identification of our lead therapeutic candidate (AER-01), establishment of preliminary safety and efficacy profiles, and the production of clinical trial API.